Aenova Group is a global leading Contract Development and Manufacturing Organisation for Pharma and Healthcare, aiming to improve the health and well-being of millions of patients worldwide. With a planned turnover of around EUR 750 million in the current financial year, the company is a key player in the global pharmaceutical and healthcare industry. The group’s portfolio of services covers the entire value chain for the development and production of all main dosage forms and product groups in the field of medicines and dietary supplements. The company, founded in 2008, has its headquarters near Munich and operates 15 sites in ten countries worldwide with around 4,300 employees. Aenova Group's high standards of quality, innovative technologies, and clear vision for the future have established it as the European market leader in the business-to-business field in the pharma industry. For more information, visit www.aenova-group.com.
There is no investment information
No recent news or press coverage available for Aenova Group.